Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Associatie amyloïdpathologie en myeline bij preklinische Alzheimer
jan 2017 | Dementie